Medexus Pharmaceuticals (TSE:MDP) has released an update.
Medexus Pharmaceuticals will showcase its industry leadership at the 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 17, where CEO Ken d’Entremont and CFO Marcel Konrad will be presenting. The company, a frontrunner in North American specialty pharmaceuticals, is known for its focus on diseases like oncology and rheumatology. Investors can tune into the live webcast of the presentation via Medexus’s website or attend in-person one-on-one meetings at the conference.
For further insights into TSE:MDP stock, check out TipRanks’ Stock Analysis page.
